Ultrahuman Bags $70 Mn To Build An Integrated Healthtech Platform
With an eye on expanding its health intelligence platform, smart ring maker Ultrahuman has raised $70 Mn (nearly ₹662 Cr)…
Smart ring manufacturer Ultrahuman has secured $70 million in fresh funding to develop an integrated healthtech platform, according to a report. The investment, led by Qualcomm Ventures, Alpha Wave, Blume, Nexus, and Alteria, will be used to bolster research and development in sensing, AI, miniaturized electronics, and health algorithms.
Additionally, the capital will help expand globally the blood testing product 'Blood Vision' and continuous glucose monitoring (CGM) platform 'M1'. CEO Mohit Kumar stated that the funds would allow Ultrahuman to delve deeper into sensing, materials, electrical engineering, algorithms, physiology, and clinical science, with the aim of bringing the technology to millions worldwide.
The startup, founded in 2019, has raised over $173 million in total funding since its inception, including recent investments from Nexus Venture Partners, Steadview Capital, Blume Ventures, and Premji Invest. Ultrahuman's platform combines data from its smart rings, Blood Vision, CGM, environmental sensors, and software and AI tools, with plans to create a broader computing platform for continuous human body signal analysis, including sleep, cardiovascular health, metabolism, hormonal rhythms, blood biomarkers, and recovery.
The company is also developing a software layer, PowerPlugs, for deriving insights and adding specialized health capabilities across various areas.
Written by urgent.news from Inc42's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
